Health Canada
- Status: approved
Mesalazine with hydrocortisone sodium succinate (Mesalazine with hydrocortisone sodium succinate) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Xijing Hospital of Digestive Diseases is the originator. The local marketing authorisation holder may differ — check the official source linked above.